Barclays Maintains Overweight on Bruker, Raises Price Target to $70
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.